An Investigation of Recovery Mechanisms for Oil Field Optimization by Three-Phase Core Flood and Simulation Studies

Two potential recovery mechanisms are being considered for a major field which required laboratory measurements to investigate the efficiency of the two scenarios: gas flood followed by water flood and water flood followed by gas flood. Although simply stated, the recovery scenarios involved complex three-phase processes which had to be replicated in the laboratory at reservoir conditions to provide reliable data upon which reservoir development decisions could be made. The first sequence consisted of water displacing oil to residual oil saturation (Sorw), oil displacing water to residual water saturation (Swro) and gas displacing both oil and water to Sor3φ,g and Swr3φ,g. The second sequence consisted of gas displacing oil to residual oil saturation (Sorg), oil displacing gas to trapped gas saturation (Sgto) and water displacing both oil and gas to Sor3φ,w and Sgt3φ,w respectively. Composite cores of four well-matched plugs at Swi were used and all measurements were made at bubble point conditions. A vertical core holder was housed inside a reservoir condition facility equipped with gamma attenuation saturation monitoring (GASM). Temperature stability and the use of GASM were paramount for the accurate measurement of produced fluids, especially trapped gas saturation. Oil, gas and water produced volumes were also measured using a separator housed inside the core flood oven to provide optimum temperature stability. The laboratory results were modelled in a compositional simulator using an equation of state tuned to conventional PVT data and both swelling and multiple contact experiments. The objective was to build a three-phase predictive model from the constituent two-phase relative permeability data. The paper details the experimental methods and presents results for each section of the two sequences. The key conclusions are that Sorg>Sorw> Sor3φ,g> Sor3φ,w and Sgt3φ,w< Sgto

Bursts in a fiber bundle model with continuous damage

We study the constitutive behaviour, the damage process, and the properties of bursts in the continuous damage fiber bundle model introduced recently. Depending on its two parameters, the model provides various types of constitutive behaviours including also macroscopic plasticity. Analytic results are obtained to characterize the damage process along the plastic plateau under strain controlled loading, furthermore, for stress controlled experiments we develop a simulation technique and explore numerically the distribution of bursts of fiber breaks assuming infinite range of interaction. Simulations revealed that under certain conditions power law distribution of bursts arises with an exponent significantly different from the mean field exponent 5/2. A phase diagram of the model characterizing the possible burst distributions is constructed.Comment: 9 pages, 11 figures, APS style, submitted for publicatio

Benchmarking of strength models for unidirectional composites under longitudinal tension

Several modelling approaches are available in the literature to predict longitudinal tensile failure of fibre-reinforced polymers. However, a systematic, blind and unbiased comparison between the predictions from the different models and against experimental data has never been performed. This paper presents a benchmarking exercise performed for three different models from the literature: (i) an analytical hierarchical scaling law for composite fibre bundles, (ii) direct numerical simulations of composite fibre bundles, and (iii) a multiscale finite-element simulation method. The results show that there are significant discrepancies between the predictions of the different modelling approaches for fibre-break density evolution, cluster formation and ultimate strength, and that each of the three models presents unique advantages over the others. Blind model predictions are also compared against detailed computed-tomography experiments, showing that our understanding of the micromechanics of longitudinal tensile failure of composites needs to be developed further

Photoelasticity of crystalline and amorphous silica from first principles

Based on density-functional perturbation theory we have computed from first principles the photoelastic tensor of few crystalline phases of silica at normal conditions and high pressure (quartz, $\alpha$-cristobalite, $\beta$-cristobalite) and of models of amorphous silica (containig up to 162 atoms), obtained by quenching from the melt in combined classical and Car-Parrinello molecular dynamics simulations. The computational framework has also been checked on the photoelastic tensor of crystalline silicon and MgO as prototypes of covalent and ionic systems. The agreement with available experimental data is good. A phenomenological model suitable to describe the photoelastic properties of different silica polymorphs is devised by fitting on the ab-initio data.Comment: ten figure

Effects of Rapid Heating on Solutionizing Characteristics of Al-Si-Mg Alloys Using a Fluidized Bed

Effects of rapid heat transfer using a fluidized bed on the heat-treating response of Al-Si-Mg alloys (both unmodified and Sr modified) were investigated. The heating rate in the fluidized bed is greater than in conventional air convective furnaces. Particle size analyses of eutectic Si showed that the high heating rate during fluidized bed solution heat treatment causes faster fragmentation and spherodization of Si particles compared to conventional air convective furnaces. The mechanism of Si fragmentation through fluidized bed processing is through both brittle fracture and neck formation and its propagation. In contrast to this, the mechanism of Si fragmentation using a conventional air convective furnace is through neck formation and propagation. The Sr-modified D357 alloy showed a faster spherodizing rate than the unmodified alloy. Thermal analyses showed an exothermic reaction during solution heat treatment using a fluidized bed due to recrystallization, and coarsening of eutectic Al grains. Whereas the alloy solutionized using a conventional air convective furnace showed two exothermic reactions, one due to annihilation of point defects and the other due to recrystallization, and coarsening of the eutectic grains in the aluminum matrix. The recrystallization temperature of the alloy solutionized in the fluidized bed is lower than those in the conventional air convective furnace. Both tensile strength and elongation of fluidized bed solutionized alloys are greater than those solutionized using the air convective furnace. The optimum heat-treatment time for T4 temper using a fluidized bed for unmodified and Sr-modified alloy was reduced to 60 and 30 minutes, respectively

Maintenance N-acetyl cysteine treatment for bipolar disorder : a double-blind randomised placebo controlled trial

Background N-acetyl cysteine (NAC) is a glutathione precursor that has been shown to have antidepressant efficacy in a placebo-controlled trial. The current study aimed to investigate the maintenance effects of NAC following eight weeks of open-label treatment for bipolar disorder.Method The efficacy of a double blind randomized placebo controlled trial of 2 g/day NAC as adjunct maintenance treatment for bipolar disorder was examined. Participants (n = 149) had a Montgomery Asberg Depression Rating Score of [greater than or equal to]12 at trial entry and, after eight weeks of open-label NAC treatment, were randomized to adjunctive NAC or placebo, in addition to treatment as usual. Participants (primarily outpatients) were recruited through public and private services and through newspaper advertisements. Time to intervention for a mood episode was the primary endpoint of the study, and changes in mood symptoms, functionality and quality of life measures were secondary outcomes.Results There was a substantial decrease in symptoms during the eight-week open-label NAC treatment phase. During the subsequent double-blind phase, there was minimal further change in outcome measures with scores remaining low. Consequently, from this low plateau, between-group differences did not emerge on recurrence, clinical functioning or quality of life measures.Conclusions There were no significant between-group differences in recurrence or symptomatic outcomes during the maintenance phase of the trial; however, these findings may be confounded by limitations. Trial Registration The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12607000074493)

Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials

<p>Abstract</p> <p>Background</p> <p>Asenapine demonstrated superiority over placebo for mania in bipolar I disorder patients experiencing acute current manic or mixed episodes in 2 randomized, placebo-and olanzapine-controlled trials. We report the results of exploratory pooled post hoc analyses from these trials evaluating asenapine's effects on depressive symptoms in patients from these trials with significant baseline depressive symptoms.</p> <p>Methods</p> <p>In the original trials (A7501004 [NCT00159744], A7501005 [NCT00159796]), 977 patients were randomized to flexible-dose sublingual asenapine (10 mg twice daily on day 1; 5 or 10 mg twice daily thereafter), placebo, or oral olanzapine 5-20 mg once daily for 3 weeks. Three populations were defined using baseline depressive symptoms: (1) Montgomery-Asberg Depression Rating Scale (MADRS) total score ≥20 (n = 132); (2) Clinical Global Impression for Bipolar Disorder-Depression (CGI-BP-D) scale severity score ≥4 (n = 170); (3) diagnosis of mixed episodes (n = 302) by investigative site screening. For each population, asenapine and olanzapine were independently compared with placebo using least squares mean change from baseline on depressive symptom measures.</p> <p>Results</p> <p>Decreases in MADRS total score were statistically greater with asenapine versus placebo at days 7 and 21 in all populations; differences between olanzapine and placebo were not significant. Decreases in CGI-BP-D score were significantly greater with asenapine versus placebo at day 7 in all categories and day 21 in population 1; CGI-BP-D score reductions were significantly greater with olanzapine versus placebo at day 21 in population 1 and day 7 in populations 2 and 3.</p> <p>Conclusions</p> <p>These post hoc analyses show that asenapine reduced depressive symptoms in bipolar I disorder patients experiencing acute manic or mixed episodes with clinically relevant depressive symptoms at baseline; olanzapine results appeared to be less consistent. Controlled studies of asenapine in patients with acute bipolar depression are necessary to confirm the generalizability of these findings.</p

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms

<p>Abstract</p> <p>Background</p> <p>The objective of this exploratory analysis was to characterize efficacy and onset of action of a 3-month treatment period with risperidone long-acting injection (RLAI), adjunctive to an individual's treatment regimen, in subjects with symptomatic bipolar disorder who relapsed frequently and had significant symptoms of mania and/or depression.</p> <p>Methods</p> <p>Subjects with bipolar disorder with ≥4 mood episodes in the past 12 months entered the open-label stabilization phase preceding a placebo-controlled, double-blind study. Subjects with significant depressive or manic/mixed symptoms at baseline were analyzed. Significant depressive symptoms were defined as Montgomery-Åsberg Depression Rating Scale (MADRS) ≥16 and Young Mania Rating Scale (YMRS) < 16; manic/mixed symptoms were YMRS ≥16 with any MADRS score. Subjects received open-label RLAI (25-50 mg every 2 weeks) for 16 weeks, adjunctive to a subject's individualized treatment for bipolar disorder (mood stabilizers, antidepressants, and/or anxiolytics). Clinical status was evaluated with the Clinical Global Impressions of Bipolar Disorder-Severity (CGI-BP-S) scale and changes on the MADRS and YMRS scales. Within-group changes were evaluated using paired <it>t </it>tests; categorical differences were assessed using Fisher exact test. No adjustment was made for multiplicity.</p> <p>Results</p> <p>162 subjects who relapsed frequently met criteria for significant mood symptoms at open-label baseline; 59/162 (36.4%) had depressive symptoms, 103/162 (63.6%) had manic/mixed symptoms. Most subjects (89.5%) were receiving ≥1 medication for bipolar disorder before enrollment. Significant improvements were observed for the total population on the CGI-BP-S, MADRS, and YMRS scales (p < .001 vs. baseline, all variables). Eighty-two (53.3%) subjects achieved remission at the week 16 LOCF end point. The subpopulation with depressive symptoms at open-label baseline experienced significant improvement on the CGI-BP-S and MADRS scales (p < .001 vs. baseline, all variables). Subjects with manic/mixed symptoms at baseline had significant improvements on the CGI-BP-S and YMRS scales (p < .001 vs. baseline, all variables). No unexpected tolerability findings were observed.</p> <p>Conclusions</p> <p>Exploratory analysis of changes in overall clinical status and depression/mania symptoms in subjects with symptomatic bipolar disorder who relapse frequently showed improvements in each of these areas after treatment with RLAI, adjunctive to a subject's individualized treatment. Prospective controlled studies are needed to confirm these findings.</p

Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd Study)

BACKGROUND: Studies in bipolar disorder (BD) to date are limited in their ability to provide a whole-disease perspective--their scope has generally been confined to a single disease phase and/or a specific treatment. Moreover, most clinical trials have focused on the manic phase of disease, and not on depression, which is associated with the greatest disease burden. There are few longitudinal studies covering both types of patients with BD (I and II) and the whole course of the disease, regardless of patients' symptomatology. Therefore, the Wide AmbispectiVE study of the clinical management and burden of Bipolar Disorder (WAVE-bd) (NCT01062607) aims to provide reliable information on the management of patients with BD in daily clinical practice. It also seeks to determine factors influencing clinical outcomes and resource use in relation to the management of BD. METHODS: WAVE-bd is a multinational, multicentre, non-interventional, longitudinal study. Approximately 3000 patients diagnosed with BD type I or II with at least one mood event in the preceding 12 months were recruited at centres in Austria, Belgium, Brazil, France, Germany, Portugal, Romania, Turkey, Ukraine and Venezuela. Site selection methodology aimed to provide a balanced cross-section of patients cared for by different types of providers of medical aid (e.g. academic hospitals, private practices) in each country. Target recruitment percentages were derived either from scientific publications or from expert panels in each participating country. The minimum follow-up period will be 12 months, with a maximum of 27 months, taking into account the retrospective and the prospective parts of the study. Data on demographics, diagnosis, medical history, clinical management, clinical and functional outcomes (CGI-BP and FAST scales), adherence to treatment (DAI-10 scale and Medication Possession Ratio), quality of life (EQ-5D scale), healthcare resources, and caregiver burden (BAS scale) will be collected. Descriptive analysis with common statistics will be performed. DISCUSSION: This study will provide detailed descriptions of the management of BD in different countries, particularly in terms of clinical outcomes and resources used. Thus, it should provide psychiatrists with reliable and up-to-date information about those factors associated with different management patterns of BD. TRIAL REGISTRATION NO: ClinicalTrials.gov: NCT01062607

Manufacturing process for high aspect ratio metallic micro parts made by electroplating on partially conductive templates

Extended Abstract In supporting structural integrity of a miniature component, or for providing electric conduction of a through-silicon via (TSV) in three-dimensional integrated circuits (3D-IC), micro-or nano-hole filling with metallic material becomes increasing important in various micro-electrical mechanical systems (MEMSs) In this study, an anodic aluminum oxide (AAO) template containing numerous high aspect ratio nano-sized holes (an average diameter of 130 nm and an aspect-ratio about 20) was used as the cathode. The hydrophobicity/hydrophilicity of the AAO template was adjusted before Cu electrodeposition. Electrodeposition of Cu was carried out in an emulsified sc-CO2 bath containing cupric sulfate aqueous solution as the precursor. Cu deposition into the nano-holes was performed at an apparent constant current density of 2 A/dm 2 for 5 minutes. After electrodeposition, the cross section morphology and chemical composition of the AAO cathode was examined by transmission electron microscopy (TEM) and energy dispersive spectroscopy (EDS) with the aid of a focused-ion-beam (FIB). The experimental results showed that electrodeposition employing sc-CO2 bath to fill Cu into nano-sized holes was successful and superior to that of conventional process carried out at ambient pressure, in terms of uniformity and deposition rate. The high solubility of hydrogen gas in sc-CO2 fluid is the key factor. Moreover, the advantage of sc-CO2 electrodeposition is more pronounced for the AAO cathode exhibiting hydrophobic nature with respect to aqueous bath. References [1] Z